The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells

Giada Marroncini(University of Florence), Alessandro Peri(University of Florence)
Journal of Endocrinological Investigation
May 23, 2022
Cited by 7


Related Papers